Akari Therapeutics (AKTX) Change in Cash (2014 - 2026)
Akari Therapeutics (AKTX) posted quarterly Change in Cash of -$2.4 million for Q1 2026, down 14223.53% year-on-year from N/an in Q1 2025, and down 189.55% on a QoQ basis from $2.7 million in Q4 2025.
Akari Therapeutics (AKTX) Change in Cash (2014 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has reported Change in Cash for 9 consecutive years, with -$2.4 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 14223.53% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186000.0 (down 86.04% YoY) and the FY2025 annual result came in at $2.6 million, up 319.56% from the prior year.
- Change in Cash fell to -$2.4 million in Q1 2026 per AKTX's latest filing, from $2.7 million in the prior quarter.
- Over the last five years, Change in Cash for AKTX reached as high as $2.9 million in Q2 2024 and fell as low as -$4.4 million in Q2 2023.
- A 4-year average of -$801692.3 and a median of -$886000.0 in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash jumped 558.35% — and 2026, when it slumped 14223.53%.
- Year by year, Change in Cash stood at -$886000.0 in 2023, then jumped by 146.61% to $413000.0 in 2024, then soared by 558.35% to $2.7 million in 2025, then tumbled by 189.55% to -$2.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$2.4 million, $2.7 million, and -$227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | -2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.44 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | -227,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 413,000.00 |
| Sep 30, 2024 | -1.93 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | -2.54 Mn |
| Dec 31, 2023 | -886,000.00 |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Dec 31, 2020 | 1.74 Mn |
| Sep 30, 2020 | -428,468.00 |
| Jun 30, 2020 | 4.92 Mn |
| Mar 31, 2020 | 2.09 Mn |
| Dec 31, 2019 | -536,976.00 |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | -3.54 Mn |